USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CATABASIS PHARMACEUTICALS, INC.
Address:
19 BLACKSTONE STREET
CAMBRIDGE, MA 02139
Phone:
N/A
URL:
N/A
EIN:
126368716
DUNS:
828787619
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $179,900.00 1

Award List:

CAT1920: A Small Molecule Therapeutic for the Treatment of IBD

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$179,900.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): 5-Aminosalicylic acid (5-ASA) and its analogs such as the prodrug sulfasalazine are front line therapy for Inflammatory Bowel Disease (IBD), which include both Crohn's disease and ulcerative colitis. 5-ASA is only moder ately efficacious in putting patients into… More